Jaguar Health Sets 1-for-15 Reverse Split for Sept 17 to Regain Nasdaq Compliance
JAGX is trading near its 52-week low of $0.292 (2.9% above the low) on elevated volume (2.1× avg).
Summary
Jaguar Health will execute a 1-for-15 reverse stock split effective September 17, 2026, to support Nasdaq listing compliance. The move follows stockholder approval at the April 2026 special meeting and comes amid a going concern warning, $3.8M cash, and heavy dilution from recent equity line registrations. The reverse split mechanically raises the share price but does not change market cap or fundamentals; it is a defensive step to avoid delisting. Trading near its 52-week low at $0.30, the company faces continued financial strain. Watch for post-split price action and any further capital raises.
At the time of this announcement, JAGX was trading at $0.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.29 to $85.40. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.